Table 2.
Comp. | Type | R1 | ENT1 inhibitory activity in K562 cells determined by flow cytometry | ||
---|---|---|---|---|---|
%Inhibition at 10μM | IC50 (nM) | Ki (nM) | |||
DMSO | - | - | 0.0 ± 0.7 | N. D.a | N. D. |
NBMPR | - | - | 97.1 ± 0.4 | 7.6 | 0.43 |
Lidoflazine | - | - | 90.0 ± 0.2 | 4954 | 279.9 |
Dipyridamole | A | 86.7 ± 0.1 | 144.8 | 8.18 | |
1 | B | 53.5 ± 0.1 | 12,229 | 690.9 | |
2 | A | 85.7 ± 0.3 | 1,764 | 99.7 | |
3 | B | 19.3 ± 1.1 | ND | ND | |
4 | A | 70.4 ± 0.4 | 6,956 | 393 | |
5 | B | 13.5 ± 0.3 | ND | ND | |
6 | A | 0.9 ± 0.7 | ND | ND | |
7 | A | 44.6 ± 2.1 | ND | ND | |
8b | A | - | 68.8 ± 0.0 | 7,947 | 449 |
9 | A | N. D. | ND | ND | |
10 | A | N. D. | ND | ND | |
11 | A | 94.4 ± 0.2 | 15.2 | 0.86 | |
12 | B | 28.7 ± 0.1 | ND | ND | |
13 | A | 93.1 ± 0.3 | 8.67 | 0.49 | |
14 | B | 78.6 ± 0.3 | 375 | 21.2 | |
15 | A | 78.0 ± 0.4 | 13.6 | 0.77 | |
16 | B | 69.3 ± 0.3 | 672 | 38 | |
17 | A | 85.0 ± 0.1 | 3,416 | 193 | |
18 | B | 14.9 ± 1.7 | ND | ND | |
19 | A | 24.7 ± 0.2 | ND | ND | |
20 | B | 16.2 ± 1.9 | ND | ND |
ND = Not Determined.
For structure of compound 8, see Scheme 1.